Showing results (191-200 of 226) with videos related to

Sort By:
Pageof 23
The New England Journal of Medicine|May 31, 2024
Efficacy and Safety of Donidalorsen for Hereditary AngioedemaMarc A Riedl, Raffi Tachdjian, William R Lumry, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2023
PI3Kδ activation, IL6 over-expression, and CD37 loss cause resistance to the targeting of CD37-positive lymphomas with the antibody-drug conjugate naratuximab emtansineAlberto J Arribas, Eugenio Gaudio, Sara Napoli, et al.
International Journal of Molecular Sciences|February 25, 2023
Accurate Detection of SARS-CoV-2 by Next-Generation Sequencing in Low Viral Load SpecimensMarius Ilié, Jonathan Benzaquen, Véronique Hofman, et al.
Lung Cancer (Amsterdam, Netherlands)|February 11, 2026
Genomic landscape of stage 0-IA lung adenocarcinoma identified by on-site reflex targeted NGSMarius Ilié, Simon Heeke, Guylène Rignol, et al.
Biopreservation and Biobanking|November 11, 2020
Establishment of a Collection of Blood-Derived Products from COVID-19 Patients for Translational Research: Experience of the LPCE Biobank (Nice, France)Virginie Tanga, Sylvie Leroy, Julien Fayada, et al.
Cell Death & Disease|December 11, 2020
Blockade of EIF5A hypusination limits colorectal cancer growth by inhibiting MYC elongationSonia Coni, Silvia Maria Serrao, Zuleyha Nihan Yurtsever, et al.
The New England Journal of Medicine|March 16, 2022
Inhibition of Prekallikrein for Hereditary AngioedemaLauré M Fijen, Marc A Riedl, Laura Bordone, et al.
Virchows Archiv : an International Journal of Pathology|December 31, 2024
EGFR status assessment using reflex testing targeted next-generation sequencing for resected non-squamous non-small cell lung cancerSamantha Goffinet, Christophe Bontoux, Simon Heeke, et al.
Blood Advances|October 7, 2024
PI3Kδ activation, IL-6 overexpression, and CD37 loss cause resistance to naratuximab emtansine in lymphomasAlberto J Arribas, Sara Napoli, Eugenio Gaudio, et al.
Cancers|March 28, 2025
Exploring the Expression of CD73 in Lung Adenocarcinoma with <i>EGFR</i> Genomic AlterationsElodie Long-Mira, Christophe Bontoux, Guylène Rignol, et al.
Pageof 23